Evaluation of a Flexible Videoscope Training Simulator
Not Applicable
Completed
- Conditions
- Difficult Airway
- Interventions
- Device: Traditional simulatorDevice: New training simulator
- First Posted Date
- 2022-04-14
- Last Posted Date
- 2022-07-13
- Lead Sponsor
- Tongji Hospital
- Target Recruit Count
- 43
- Registration Number
- NCT05327842
- Locations
- 🇨🇳
Department of Anesthesiology, Tongji Hospital, Wuhan, Hubei, China
Fecal Microbiota Transplantation as the First-line Treatment in Active Pediatric Crohn's Disease
Not Applicable
Recruiting
- Conditions
- Crohn Disease
- Interventions
- Biological: Fecal Microbiota TransplantationDrug: Immunosuppressive Agents
- First Posted Date
- 2022-04-11
- Last Posted Date
- 2025-04-11
- Lead Sponsor
- Tongji Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT05321758
- Locations
- 🇨🇳
Tongji Hospital, Wuhan, Hubei, China
A Study Evaluating the Efficacy of Secukinumab 300mg in Chinese Adults With Active Ankylosing Spondylitis
Phase 4
- Conditions
- Ankylosing Spondylitis (AS)
- Interventions
- First Posted Date
- 2022-03-31
- Last Posted Date
- 2022-03-31
- Lead Sponsor
- Tongji Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT05303285
- Locations
- 🇨🇳
Department of RheumatologyTongji Hospital, Wuhan, Hubei, China
🇨🇳Tongji Hospital, Wuhan, Hubei, China
A Study to Evaluate Efficacy and Safety of Abatacept in Participants of Pemphigus Vulgaris (PV)
Phase 4
- Conditions
- Pemphigus Vulgaris
- Interventions
- First Posted Date
- 2022-03-31
- Last Posted Date
- 2022-03-31
- Lead Sponsor
- Tongji Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT05303272
- Locations
- 🇨🇳
Tongji Hospital, Wuhan, Hubei, China
A Study Evaluating the Efficacy and Safety of Baricitinib in Systemic Sclerosis
- First Posted Date
- 2022-03-29
- Last Posted Date
- 2022-03-29
- Lead Sponsor
- Tongji Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT05300932
- Locations
- 🇨🇳
Department of RheumatologyTongji Hospital, Wuhan, Hubei, China
🇨🇳Tongji Hospital, Wuhan, Hubei, China
The Predictive Role of HPV Integration in HSIL and Cervical Cancer
- Conditions
- HPV Integration
- First Posted Date
- 2022-03-29
- Last Posted Date
- 2022-03-29
- Lead Sponsor
- Tongji Hospital
- Target Recruit Count
- 1
- Registration Number
- NCT05300243
- Locations
- 🇨🇳
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China
Circulating Tumor Cell Detection in Hepatocellular Carcinoma
Completed
- Conditions
- Circulating Tumor Cell
- First Posted Date
- 2022-03-28
- Last Posted Date
- 2022-04-06
- Lead Sponsor
- Tongji Hospital
- Target Recruit Count
- 458
- Registration Number
- NCT05297955
- Locations
- 🇨🇳
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
Central China Rosai-Dorfman Disease Registry
Phase 4
- Conditions
- Rosai-Dorfman DiseaseLangerhans Cell Histiocytosis
- Interventions
- First Posted Date
- 2022-03-17
- Last Posted Date
- 2022-03-17
- Lead Sponsor
- Tongji Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT05284942
- Locations
- 🇨🇳
Tongji Hospital, Wuhan, Hubei, China
A Multi-Omics Study of Vasospastic Angina
- Conditions
- Vasospastic Angina
- First Posted Date
- 2022-03-16
- Last Posted Date
- 2022-03-16
- Lead Sponsor
- Tongji Hospital
- Target Recruit Count
- 1200
- Registration Number
- NCT05282511
- Locations
- 🇨🇳
Tongji Hospital, Wuhan, Hubei, China
A Clinical Study of DEB-TACE Combined With Surufatinib and Camrelizumab in the Treatment of Inoperable or Metastatic ICC
Phase 2
Completed
- Conditions
- Intrahepatic Cholangiocarcinoma
- Interventions
- Combination Product: DEB-TACE combined with Surufatinib and Camrelizumab
- First Posted Date
- 2022-02-11
- Last Posted Date
- 2025-02-14
- Lead Sponsor
- Tongji Hospital
- Target Recruit Count
- 23
- Registration Number
- NCT05236699
- Locations
- 🇨🇳
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
© Copyright 2025. All Rights Reserved by MedPath